7Baggers
 transcript : pavmed inc., q2 2025 earnings call, aug 14, 2025  MarketScreener Thu, 02 Oct 2025 19:51:07 GMT
 lucid diagnostics appoints john r. palumbo to board  The Globe and Mail Fri, 26 Sep 2025 13:26:00 GMT
 lucid diagnostics appoints john r. palumbo to board  citybiz Thu, 25 Sep 2025 16:12:46 GMT
 lucid diagnostics appoints healthcare veteran john palumbo to board by investing.com  Investing.com South Africa Thu, 25 Sep 2025 12:44:13 GMT
 duke university to license endoscopic esophageal imaging tech to pavmed  Medical Product Outsourcing Fri, 12 Sep 2025 07:00:00 GMT
 lucid diagnostics announces public stock offering  MSN Thu, 11 Sep 2025 14:29:11 GMT
 PAVmed’s Lucid Diagnostics Completes Public Stock Offering  TipRanks Thu, 11 Sep 2025 07:00:00 GMT
 lucid diagnostics announces public stock offering  MSN Wed, 10 Sep 2025 07:00:00 GMT
 lucid diagnostics slides on $25 mln stock sale  TradingView Wed, 10 Sep 2025 07:00:00 GMT
 Lucid Diagnostics Announces Proposed Public Offering of Common Stock  Financial Times Tue, 09 Sep 2025 07:00:00 GMT
 lucid diagnostics advances towards medicare coverage  MSN Mon, 08 Sep 2025 08:56:53 GMT
 published on: 2025-09-02 14:53:14  Newser Tue, 02 Sep 2025 19:53:14 GMT
 PAVmed plans to license Duke’s oesophageal imaging technology  Medical Device Network Thu, 28 Aug 2025 07:00:00 GMT

PAVmed Inc
(NASDAQ:PAVM) 

PAVM stock logo

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophag...

Founded: 2014
Full Time Employees: 15
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends